Investing.com - Aravive reported on Thursday third quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Aravive announced earnings per share of $-0.510 on revenue of $4.96M. Analysts polled by Investing.com EPS of $-0.620 on revenue of $960K.
Aravive 's are down 23.1% and is trading at $1.350 , still down 67.70% from its 52 week high of $4.18 set on Wednesday, November 10, 2021.
Aravive follows other major Healthcare sector earnings this month
Aravive's report follows an earnings beat by UnitedHealth on Friday, October 14, 2022, who reported EPS of $5.79 on revenue of $80.89B, EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on Tuesday, October 18, 2022 with third quarter EPS of $2.55 on revenue of $23.79B, for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar